FDA Approves Foundayo (Orforglipron): Lilly’s Game-Changing Oral GLP-1 Pill for Weight Loss – No Food or Water Restrictions Required
FDA Approves Foundayo (Orforglipron): Lilly’s Game-Changing Oral – In a major win for millions of Americans struggling with obesity, the U.S. Food and Drug Administration has officially approved Eli Lilly and Company’s newest weight-loss medication. Foundayo™ (orforglipron) is now the only once-daily GLP-1 pill that can be taken any time of day, with or without … Read more